Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 2Phase 3 1Phase 2/3 1Phase 1 1

Status

Recruiting 2Not yet recruiting 2Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 4Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 4Prostatic Neoplasms 1

Interventions

pembrolizumab 524Specimen Handling 383Carboplatin 377Magnetic Resonance Spectroscopy 336Cisplatin 332Nivolumab 308Cyclophosphamide 298Radiotherapy 257Paclitaxel 255Gemcitabine 235Biopsy 235Bevacizumab 218Dexamethasone 169durvalumab 168Oxaliplatin 163Capecitabine 158Rituximab 157Fluorouracil 149venetoclax 147Docetaxel 147Etoposide 142Drug Therapy 142atezolizumab 141Doxorubicin 134Ipilimumab 129Radiosurgery 120Prednisone 120Lenalidomide 119Leucovorin 113fludarabine 109

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Homoharringtonine × 1 year × Clear all
NCT07507825 2026-04-02

VHAG

First People's Hospital of Hangzhou

Phase 2 Not yet recruiting
61 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07505160 2026-04-01

Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting
35 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06483906 2026-03-03

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
56 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05906914 2026-02-04

CHA

First Affiliated Hospital of Zhejiang University

Phase 2 Completed
65 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07163910 2025-11-18

Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study

Zhongda Hospital

Phase 2 Recruiting
93 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡